FTC's Provigil Pay-For-Delay Suit Passes Actavis Test: Judge
A Pennsylvania federal judge on Wednesday ruled that the Federal Trade Commission's pay-for-delay suit against drugmaker Cephalon Inc. over its Provigil narcolepsy drug meets the U.S. Supreme Court's Actavis standard allowing...To view the full article, register now.
Already a subscriber? Click here to view full article